Shuchi Patel, MD: Good afternoon, Dr. Ruth Williams. Thank you so much for taking the time to have a discussion with us regarding a topic that is of emerging interest. Today we're going to talk about ...

Glaucoma therapies have come a long way, but pain points still remain, according to a speaker at the American Academy of ...

Although most of the innovation in treatment has come in the past decade, new treatments for glaucoma are still being tested, albeit at a slower pace. Jonathan Eisengart, MD, an ophthalmologist at ...

Please provide your email address to receive an email when new articles are posted on . Concerns about glaucoma had a negative impact on medication adherence. Illness perception also had an impact on ...

From MIGS integration to remote monitoring and next-generation therapeutics, glaucoma specialists explore how new approaches ...

Medication, laser, and surgery are all methods of treating glaucoma according to Jonathan Eisengart, MD. Jonathan Eisengart, MD, an ophthalmologist at Cleveland Clinic, explained how different ...

Expert Rev Ophthalmol. 2010;5(3):405-412. Damage and inflammation of the corneal epithelium can cause an increase of inflammatory cells, detected by confocal microscopy, and inflammatory mediators.

Glaucoma, caused by high pressure within the eye, affects some 2.5 million Americans and is the nation's second leading cause of blindness. Optometrists screen for it during routine eye exams, often ...

Background/Aims The neuroprotective effect of nicotinamide (NAM) supplementation has been demonstrated in both animal models ...

Scientists at Mizzou have identified two small molecules, agmatine and thiamine, that could both reveal and fight glaucoma.